Navigation Links
Autistic Individuals can Be 'trained' to Comprehend Visual and Vocal Cues

between the ages of 7 and 17, as well as a control group of 18 typically developing (TD) boys, viewed cartoon drawings of children in conversational settings while listening to short vignettes that ended with a potentially ironic remark.

Researchers found that, compared with the TD control group, the ASD children had reduced activity in two areas of the brain - the medial prefrontal cortex and right superior temporal gyrus. But when the researchers gave both groups explicit instructions to pay attention to the speaker's facial expression and tone of voice, only the ASD children showed a significant increase in activity in the medial prefrontal cortex.

"The typically developing kids recognized and interpreted these cues automatically when trying to infer if a speaker's remark was sincere or sarcastic, so their brains were already responding appropriately," said Dapretto.

"But not so with the ASD kids, who did not show activity in this area when specific instructions weren't provided. This is the first study to show that you can normalize activity in a key region of the so-called 'social brain' in individuals with autism by simply directing their attention to these important social cues," Dapretto said.

The study, that is available online, is published in the current issue of the journal Archives of General Psychiatry.


'"/>




Page: 1 2

Related medicine news :

1. Study Proves That MMR Vaccine Is Not Connected To Autistic Babies
2. Autistic traits evident in relatives
3. Novel Device Developed To Help Autistic Individuals Communicate Better
4. MMR Vaccine May Be A Reason Behind Autistic Children, Study Finds
5. Ontario Continues Support for Autistic Children
6. Fewer Neurons in Amygdala of Autistic Males
7. Caregiver Charged In Autistic Boys Death
8. Autistic Children Need Sense of Equality: A.P.J. Abdul Kalam
9. Risperdal Cleared By FDA To Treat Autistic Children
10. FDA Gives the Nod to Risperdal For Use in Autistic Children
11. Autistic Children May Lag behind in ‘Categorization of Objects
Post Your Comments:
(Date:9/5/2008)... Saturday, September 6, PARI,Respiratory Equipment...,s,Family as part of their "Breathe Easier" series...company that provides patients, such as COPD,suffe...at deliver needed,medications directly to the lung...affected by respiratory,diseases and those who car...
(Date:9/5/2008)...ht or obese at age 45 , , FRIDAY, Sept. ...adults will develop osteoarthritis of the knee by ...in middle age, a new study says. , A person,s ...his or her body-mass index (BMI) rose, according t...study. People who were of normal weight at age 18 ...
(Date:9/5/2008)...are enhanced by taking into account risk factors b...ding to research teams led by epidemiologists at T...r in two complementary papers appearing in the Sep...In the first study to focus on African-Americans, ...d exposure to certain risks. Based upon these find...
(Date:9/4/2008)...care Advantage (MA) plans will be paid an average ... what the same enrollee would have cost in the tra...ng to a new report from The Commonwealth Fund. Ev...by the Medicare Improvements for Patients and Prov...t beginning in 2010 had been fully in place in 20...
Breaking Medicine News(10 mins):Health News:PARI Respiratory Equipment Featured on Oxygen Network 2Health News:Almost Half of Adults Will Develop Knee Osteoarthritis by 85 2Health News:Creating lung cancer risk models for specific populations refines prediction 2Health News:Creating lung cancer risk models for specific populations refines prediction 3Health News:Extra payments to Medicare Advantage plans to total $8.5 billion in 2008 2
...ed alert due to Chikungunya outbreak in the city a...elfare.// In spite of the efforts of the Health ...d the disease at source, the mosquitoes continue t...eues of patient’s suffering from the disease. C...
...as a hazard of aging, but researchers actually do ...consequence of aging// or not. Researchers at the ...pps Research Institute have now conducted a study ...al for diseases like Alzheimer's. Harmful beta am...
...g users who completed the treatment for drug addic... number of people enrolling// for the treatment in...out of treatment if they had been coerced into it ...ntered by other routes. This was reported by a Bri...
...e in the American Society, not only among women bu...men under pressure to have a good physique may suf...s, and an unhealthy preoccupation with weightlifti...muscular men in the media and feel their own bodie...
Other Medicine News:Health News:Chikungunya Outbreak 2Health News:Aging Critical For Alzheimer's Disease 2Health News:Aging Critical For Alzheimer's Disease 3Health News:Men Take to Unhealthy Practices to be More Muscular 2
(Date:9/4/2008)... on Schedule with Two Abstracts Accepted for P...vember 2008, BRIDGEWATER, N.J., Sept. 4 /PRNewswi... pharmaceutical company focused on the treatment o...unced the appointment of,Peter L. Garrambone, Jr. ...mbone,s career includes more than 50 pharmaceutica...
(Date:9/3/2008).../- Simcere,Pharmaceutical G...plier of,branded generic pharmaceuticals and manuf...t Endu (also known as Endostar) in China,announce...udy., At the request of the SFDA, Simcere initiat...he safety and therapeutic efficacy of Endu, a modi...
(Date:9/3/2008)...onal Vascular Disease Awareness Month, CHARLOTTES...maceuticals,LLC, a clinical-stage drug-development...nt of unmet medical needs, announced today that it...ical trial of its lead drug,candidate trans sodium...881,on the clinicaltrials.gov Website, is investig...
(Date:9/3/2008)...Multaq(R) (dronedarone) decreased the risk of,stro...trial flutter already adequately trea... Sept. 3 /- The results of ...udy were presented today at,the clinical trial upd...congress 2008, in Munich, Germany. Previous result...
Breaking Medicine Technology:Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients Lives 7826 1Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients Lives 7826 2Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients Lives 7826 3Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients Lives 7826 4Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients Lives 7826 5Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients Lives 7826 6Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients Lives 7826 7Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients Lives 7826 8Submission of Marketing Authorisation Application for Dapoxetine in Europe 7823 1Submission of Marketing Authorisation Application for Dapoxetine in Europe 7823 2Katie Lee Joel to Conduct Free Hands On Holiday Cooking Demonstration for Local Patients With Chronic Kidney Disease 2103 1Katie Lee Joel to Conduct Free Hands On Holiday Cooking Demonstration for Local Patients With Chronic Kidney Disease 2103 2Katie Lee Joel to Conduct Free Hands On Holiday Cooking Demonstration for Local Patients With Chronic Kidney Disease 2103 3Katie Lee Joel to Conduct Free Hands On Holiday Cooking Demonstration for Local Patients With Chronic Kidney Disease 2103 4Katie Lee Joel to Conduct Free Hands On Holiday Cooking Demonstration for Local Patients With Chronic Kidney Disease 2103 5Katie Lee Joel to Conduct Free Hands On Holiday Cooking Demonstration for Local Patients With Chronic Kidney Disease 2103 6Katie Lee Joel to Conduct Free Hands On Holiday Cooking Demonstration for Local Patients With Chronic Kidney Disease 2103 7Tutogen Medical Inc to Report Fourth Quarter and Fiscal Year 2007 Financial Results 2100 1Tutogen Medical Inc to Report Fourth Quarter and Fiscal Year 2007 Financial Results 2100 2
...007 – On 23 July SYGNIS Pharma,AG will prese...,AX200 (AXIS-study)., AX200, a compound for the tr...date in SYGNIS’ product pipeline. The,primar...ity of,AX200 in acute stroke patients. The results...tion for the further clinical,development of AX200...
...swire-FirstCall/ -- On Wednesday,July 11, 2007, a...entral European Time members of Cell Therapeutics,...ce call to discuss today,s,announcement of the int...ring CHOP-R to CPOP-R, in which pixantrone is subs...st-line treatment of patients,with aggressive non-...
Other Medicine Technology:Sygnis Pharma AG announces date for presentation of clinical,results 2Cell Therapeutics, Inc. Management to Discuss Today's Announcement,of Interim Pixantrone Study Results 2
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: